When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 147 Hits
  • Search Condition : Filter (MeSH = Lung Neoplasms / genetics)
Species Resource Title
Human and Animal Cells SCLC cell lines (Lu cells) Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
Human and Animal Cells A549 Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.
Human and Animal Cells LK-28RCB1970) , EBC-1(RCB1965) Loss of GSTO2 contributes to cell growth and mitochondria function via the p38 signaling in lung squamous cell carcinoma.
Human and Animal Cells HPB-ALL(RCB1935) A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays.
Human and Animal Cells II-18(RCB2093) , PC-14(RCB0446) , RERF-LC-KJ(RCB1313) Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines.
Human and Animal Cells A549 , PC-9(RCB4455) Repression of RhoJ expression promotes TGF-β-mediated EMT in human non-small-cell lung cancer A549cells.
Human and Animal Cells Ba/F3(RCB0805) Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation.
Human and Animal Cells G-361(RCB0991) , SK-MEL-28(RCB1930) , COLO 679(RCB0989) , HMV-II(RCB0777) Actin-binding protein, Espin: a novel metastatic regulator for melanoma.
Human and Animal Cells PC-14(RCB0446) Identification of a nuclear protein, LRRC42, involved in lung carcinogenesis.
Human and Animal Cells EBC-1(RCB1965) , LK-2(RCB1970) Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
Human and Animal Cells LU99(RCB1900) , LU65(RCB1967) , IA-LM(RCB0554) The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.
DNA material CSII-CMV-MCS (RDB04377) , CS-RfA-CMV-mRFP1 (RDB05747) , pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.
Human and Animal Cells LC-2/ad(RCB0440) Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients.
Human and Animal Cells PC-9(RCB4455) Suppression of tumor immune microenvironment via microRNA-1 after epidermal growth factor receptor-tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma.
Human and Animal Cells A549(RCB0098) , LC-2/ad(RCB0440) , RERF-LC-KJ(RCB1313) MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
Human and Animal Cells RERF-LC-KJ(RCB1313) , LC-1/sq(RCB0455) , RERF-LC-AI(RCB0444) , MS-1(RCB0725) PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
Human and Animal Cells Ba/F3 Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib.
Human and Animal Cells PC-9(RCB4455) Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.
Human and Animal Cells PC-9(RCB4455) Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.
Human and Animal Cells Lu-130(RCB0465) PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer.